Tony Russell, PhD MBA
Tony Russell, PhD MBA
  • 14
  • 5 012
Market Sizing for Early-Stage Programs in the Biopharmaceutical Industry
In this module, I cover the topic of building forecast assessments for early- to mid-stage programs. Developing forecasts for early programs is one of the core capabilities within new product planning. For this module, I will be covering the high-level aspects of developing forecasts that are stage appropriate. I've listed additional resources below, so please feel free to review those materials. The views and opinions expressed in this presentation are solely mine and do not represent those of my current or previous employers.
Resources
“New Product Planning Playbook, v1.0” from the Biopharma NPP Network (www.biopharma-newproductplanning.com/npp-playbook)
“Forecasting for the Pharmaceutical Industry: Models for New Product and In-Market Forecasting and How to Use Them” by Arthur Cook
Forecasting Best Practices Across Product Stages [NPP Forum] (www.biopharma-newproductplanning.com/forums2)
Inflation Reduction Act - Impact on Pipeline Development: A Round Table Discussion [NPP Forum] (www.biopharma-newproductplanning.com/forums2)
Biopharma New Product Planning Network: www.biopharma-newproductplanning.com
มุมมอง: 499

วีดีโอ

Focus on Out-Licensing - Summary by Mike Foorer
มุมมอง 532 ปีที่แล้ว
Summary: Video summary by Mike Foorer (AmacaThera) from the Aug 3, 2022 New Product Planning Forum "Comparing and Contrasting In-Licensing vs. Out-Licensing". The Outcomes report from the NPP Forum can be found at bit.ly/3PqbQju. www.biopharma-newproductplanning.com #NewProductPlanning, #Pharmaceutical, #Biotechnology, #PipelineStrategy, #businessdevelopment
Asymmetries in In-Licensing and Out-Licensing - Summary by Joe Melvin
มุมมอง 732 ปีที่แล้ว
Video summary by Joe Melvin (IQVIA) from the Aug 3, 2022 New Product Planning Forum "Comparing and Contrasting In-Licensing vs. Out-Licensing". The Outcomes report from the NPP Forum can be found at bit.ly/3PqbQju. www.biopharma-newproductplanning.com #NewProductPlanning, #Pharmaceutical, #Biotechnology, #PipelineStrategy, #businessdevelopment
New Product Planning and Licensing Activities - Summary by Pankaj Oza
มุมมอง 532 ปีที่แล้ว
Video summary by Pankaj Oza (Blue Matter Consulting) from the Aug 3, 2022 New Product Planning Forum "Comparing and Contrasting In-Licensing vs. Out-Licensing". The Outcomes report from the NPP Forum can be found at bit.ly/3PqbQju. www.biopharma-newproductplanning.com #NewProductPlanning, #Pharmaceutical, #Biotechnology, #PipelineStrategy, #businessdevelopment
Competitive Intelligence in New Product Planning
มุมมอง 2492 ปีที่แล้ว
In this presentation, I cover the topic of competitive intelligence in new product planning. For this module, I review the key steps in conducting competitive intelligence as well as best practices in developing key intelligence questions. I also cover how to work effectively with external CI firms as well as the value of strategic simulation exercises. This module is part of a series derived f...
"How to Plan for the Growing Contribution of China in Value Creation" by Helen Chen
มุมมอง 372 ปีที่แล้ว
In this video clip extracted from the Jan 2022 Forum on "How to Plan for the Growing Contribution of China in Value Creation" by Helen Chen (Head of China Life Sciences and Healthcare at L.E.K.) synthesizes through key strategic questions how to successfully plan the entry of innovative medicines in China. Refer to Forum's outcome decks (2021.11.11 & 2022.01.19) for more insights & resources.
Starting a Career in New Product Planning
มุมมอง 2722 ปีที่แล้ว
This presentation is for those interested in starting a career in new product planning. In this module, I cover the key questions I've received from the wonderful conversations I've had with people looking to make a career transition into the NPP function. I discuss the range of responsibilities typically described for new product planning positions as well as the experience needed for an effec...
Decision Making in New Product Planning
มุมมอง 2412 ปีที่แล้ว
In this presentation, I cover the topic of decision making in new product planning. For this module, I review the types of decisions typically made in new product planning. The module discusses the nature of information available to support decision making. The impact and strategic context of decision making in new product planning is addressed. And we'll review potential approaches to assist i...
Lifecycle Management in the Pharmaceutical Industry
มุมมอง 2.6K2 ปีที่แล้ว
In this presentation, I cover the topic of lifecycle management (LCM) in the pharmaceutical industry. The module provides an overview of the key factors driving the need for lifecycle management and the benefits of successfully implementing an effective strategy. The presentation includes a brief summary of the different successful LCM strategies that companies have delivered for their brands. ...
New Product Planning Toolbox
มุมมอง 1623 ปีที่แล้ว
This module covers the different elements that comprise the New Product Planning toolbox. The components described in the video can be helpful in building a strong business case for a program. The video is meant to be a companion to a slide deck on the same topic that can be accessed at: www.biopharma-newproductplanning.com/resources. #NewProductPlanning, #Pharmaceutical, #Biotechnology, #Pipel...
Summary of Positioning Pharmaceuticals Workshop
มุมมอง 1703 ปีที่แล้ว
Summary of the New Product Planning Workshop ("Positioning Pharmaceuticals: How do you build a stage-appropriate positioning to maximize the potential of your asset?") held on October 6, 2021. The Workshop was led by Jacqui Barendregt, Principal & Head of Client Services at IDEA Pharma. Slides from the Workshop along with the accompanying PDF eBook on Pharmaceutical Positioning can be found at ...
Killing a Program in New Product Planning
มุมมอง 1143 ปีที่แล้ว
In this module, I cover one of the more challenging issues in new product planning: killing a program. The module covers what defines a weak program and why it is important to deprioritize or kill a weak program. The module reviews objective mechanisms to evaluate the strengths and weaknesses of a program and how teams can approach the challenging situation when a program's fate needs to be dec...
Prioritizing Indications in New Product Planning
มุมมอง 2253 ปีที่แล้ว
In this module, I cover one of the more common exercises in new product planning: prioritizing indications. The module covers the overall process in terms of the evaluation team and goals. Examples are provided for evaluation scoring and summary visualizations to assist in the prioritization exercise. This module is part of a series derived from different professional and teaching engagements o...
Value of New Product Planning
มุมมอง 2743 ปีที่แล้ว
In this module, I cover why New Product Planning plays an important role in drug development. The module covers the challenges associated with decreasing R&D productivity in the pharmaceutical industry and how the goals in drug development continue to evolve. The module also describes how New Product Planning is defined and how the role is distinct from traditional marketing roles. This module ...

ความคิดเห็น

  • @melprima
    @melprima 24 วันที่ผ่านมา

    Fantastic video, thank you so much!

  • @saturn0152
    @saturn0152 3 หลายเดือนก่อน

    Tysm for providing these insightful informations without any fee. You are a blessing.

  • @Ankumani17
    @Ankumani17 3 หลายเดือนก่อน

    Insightful, keep posting.

  • @chocoletboy18
    @chocoletboy18 4 หลายเดือนก่อน

    Great learning. Thanks

  • @jhingerjhol
    @jhingerjhol 5 หลายเดือนก่อน

    Is there any updated version of this webinar which describe advanced version of Competitive Intelligence

    • @tonyrussellphdmba2257
      @tonyrussellphdmba2257 4 หลายเดือนก่อน

      Thank you for your note. A good place to start is the Strategic Consortium of Intelligence Professionals (SCIP): www.scip.org/. This group is not specific to the pharma industry but provides deeper background and tools on the discipline. I'm not aware of any available webinars on CI in pharma outside of what CI agencies provide. For example, here is one from Fuld and Company: www.fuld.com/learning-from-leaders-competitive-intelligence-in-health-life-sciences/.